Eli Lilly (NYSE:LLY)'s recent foray into the weight-loss market with the approval of its diabetes drug Mounjaro for weight management signals a strategic expansion for the...
NEW YORK - Bristol Myers (NYSE:BMY) Squibb Co. (NYSE:BMY) experienced a downturn on Thursday, ending a two-day streak of gains as its shares dropped 1.42% to close at $50.84. The...
NEW YORK - Pfizer Inc. (NYSE:PFE) has announced a significant workforce reduction at its Sandwich, Kent, U.K. facility, impacting 500 employees, primarily scientists, as the...
Pfizer (NYSE:PFE)'s Third Quarter 2023 Earnings Call highlighted a strong performance from its non-COVID products, a busy pipeline with multiple upcoming launches, and...
Pfizer Inc. (NYSE:PFE)'s shares experienced a marginal increase of 0.03% to $30.56 on Tuesday, marking the second day of consecutive gains in a favorable market environment....
Investing.com -- Pfizer (NYSE:PFE) has reported its first quarterly loss since 2019, while revenue also missed estimates, as the drugmaker was hit by charges linked to its...
Investing.com - Pfizer (NYSE: PFE) reported third quarter EPS of $-0.17, $0.09 worse than the analyst estimate of $-0.08. Revenue for the quarter came in at $13.2B versus the...
Pfizer Inc. (NYSE:PFE) today announced topline data from the Phase 2b clinical trial (NCT04707313) investigating its oral Glucagon-like peptide-1 receptor agonist (GLP-1RA)...
Astellas Pharma Inc. and Pfizer Inc. (PFE) today announced that the companies received an approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug...